Cargando…

Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China

BACKGROUND: The male gamete fertilization factor P48/45 in malaria parasites is a prime transmission-blocking vaccine (TBV) candidate. Efforts to develop antimalarial vaccines are often thwarted by genetic diversity of the target antigens. Here we evaluated the genetic diversity of Pvs48/45 gene in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Hui, Gupta, Bhavna, Wang, Meilian, Zheng, Wenqi, Zheng, Li, Zhu, Xiaotong, Yang, Yimei, Fang, Qiang, Luo, Enjie, Fan, Qi, Tsuboi, Takafumi, Cao, Yaming, Cui, Liwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665908/ https://www.ncbi.nlm.nih.gov/pubmed/26627683 http://dx.doi.org/10.1186/s13071-015-1232-4

Ejemplares similares

Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China
por: Feng, Hui, et al.
Publicado: (2011)

Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45
por: Vallejo, Andres F., et al.
Publicado: (2016)

Genetic diversity in the transmission-blocking vaccine candidate Plasmodium vivax gametocyte protein Pvs230 from the China–Myanmar border area and central Myanmar
por: Zhao, Xin, et al.
Publicado: (2022)

Evaluation of two Plasmodium vivax sexual stage antigens as transmission-blocking vaccine candidates
por: Zhang, Yongzhe, et al.
Publicado: (2021)

Evolution of the Transmission-Blocking Vaccine Candidates Pvs28 and Pvs25 in Plasmodium vivax: Geographic Differentiation and Evidence of Positive Selection
por: Chaurio, Ricardo A., et al.
Publicado: (2016)

Genetic diversity of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax isolates from China
por: Wang, Siqi, et al.
Publicado: (2022)

Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine
por: Kou, Xu, et al.
Publicado: (2016)

Erratum to: Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine
por: Kou, Xu, et al.
Publicado: (2017)

Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate
por: Zheng, Wenqi, et al.
Publicado: (2017)

Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast Asia
por: Wang, Meilian, et al.
Publicado: (2016)

Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems
por: Arévalo-Herrera, Myriam, et al.
Publicado: (2021)

Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax
por: Blagborough, A.M., et al.
Publicado: (2016)

Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission
por: Wang, Jian, et al.
Publicado: (2017)

Recombinant Pvs48/45 Antigen Expressed in E. coli Generates Antibodies that Block Malaria Transmission in Anopheles albimanus Mosquitoes
por: Arévalo-Herrera, Myriam, et al.
Publicado: (2015)

Expression of concern on: Immunoreactivity of sera from low to moderate malaria-endemic areas against plasmodium vivax rPvs48/45 proteins produced in Escherichia coli and Chinese hamster ovary systems
Publicado: (2023)

Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii
por: Zheng, Li, et al.
Publicado: (2016)

Exploration of genetic diversity of Plasmodium vivax circumsporozoite protein (Pvcsp) and Plasmodium vivax sexual stage antigen (Pvs25) among North Indian isolates
por: Kaur, Hargobinder, et al.
Publicado: (2019)

Characterization of a Sulfhydryl Oxidase From Plasmodium berghei as a Target for Blocking Parasite Transmission
por: Zheng, Wenqi, et al.
Publicado: (2020)

Tryptophan-rich domains of Plasmodium falciparum SURFIN(4.2) and Plasmodium vivax PvSTP2 interact with membrane skeleton of red blood cell
por: Zhu, Xiaotong, et al.
Publicado: (2017)

Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination
por: Ngassa Mbenda, Huguette Gaelle, et al.
Publicado: (2020)

Molecular Evolution of PvMSP3α Block II in Plasmodium vivax from Diverse Geographic Origins
por: Gupta, Bhavna, et al.
Publicado: (2015)

Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1
por: Tentokam, Bergeline C. Nguemwo, et al.
Publicado: (2019)

Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study
por: Kosasih, Ayleen, et al.
Publicado: (2021)

Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates
por: Nicholas, Justin, et al.
Publicado: (2023)

Plasmodium vivax populations revisited: mitochondrial genomes of temperate strains in Asia suggest ancient population expansion
por: Miao, Miao, et al.
Publicado: (2012)

Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent
por: Prajapati, Surendra K, et al.
Publicado: (2011)

Analysis of Pvama1 genes from China-Myanmar border reveals little regional genetic differentiation of Plasmodium vivax populations
por: Zhu, Xiaotong, et al.
Publicado: (2016)

New Plasmodium vivax Genomes From the China-Myanmar Border
por: Brashear, Awtum M., et al.
Publicado: (2020)

Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
por: Ko, Kuang-Ting, et al.
Publicado: (2022)

Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening
por: Fabbri, Camila, et al.
Publicado: (2021)

Polysaccharides from the Chinese medicinal herb Achyranthes bidentata enhance anti-malarial immunity during Plasmodium yoelii 17XL infection in mice
por: Zhu, Xiaotong, et al.
Publicado: (2012)

Controlling Electronics Boards with PVS
Publicado: (2005)

Genetic diversity, natural selection and haplotype grouping of Plasmodium vivax Duffy-binding protein genes from eastern and western Myanmar borders
por: Hu, Yubing, et al.
Publicado: (2019)

Phosphatase inhibitors BVT-948 and alexidine dihydrochloride inhibit sexual development of the malaria parasite Plasmodium berghei
por: Jia, Xitong, et al.
Publicado: (2022)

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
por: Wu, Yimin, et al.
Publicado: (2008)

Functional Conservation of P48/45 Proteins in the Transmission Stages of Plasmodium vivax (Human Malaria Parasite) and P. berghei (Murine Malaria Parasite)
por: Cao, Yi, et al.
Publicado: (2018)

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
por: Lennartz, Frank, et al.
Publicado: (2018)

Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum
por: McLean, Alistair R. D., et al.
Publicado: (2017)

Transmission efficiency of Plasmodium vivax at low parasitaemia
por: Surit, Thitiporn, et al.
Publicado: (2023)

Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates
por: Kang, Jung-Mi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hcsoavonohf12ss06pjchge71f